Full disclosure first, then the detail.
A substitution without prior notice is defensible when it is the same molecule and dose, but consent should come first.
Packaging was plain, intact, and the batch was legible.
Will update the thread if anything changes.
Half of what people describe as tolerance is a change in the underlying condition, and the two need different answers. Currently on a short-dated batch myself.
Enteric coatings should not be crushed. The pellets are the delivery mechanism. Four months in on a short-dated batch and it lines up.
Access to mugs should be on the clinical questionnaire.
Everyone here blames the drug. Half the time it is the appointment schedule, not the molecule.
My pharmacist has become my actual doctor and I am at peace with it.
You are not imagining it and you are not being difficult. Document it and take the document in.
Function over score.
Print the page.
My pharmacist has become my actual doctor and I am at peace with it.
Same shape here, different drug. The thing that helped was documenting the refusal rather than re-arguing it. They refer rather than write.
Is it normal to feel worse before better? Nobody told me that.
Access to mugs should be on the clinical questionnaire.
Interdose restlessness is distinct from the original symptom and worth naming separately.
Personal experience, labelled as such, is exactly right here. Nobody is prescribing.